
Activity Information
Activity Description
The EGFR Resisters Research Summit (EGFR-RRS) is a unique program built for the next generation of clinical- and lab-based scientists advancing the field of EGFR-mutant non-small cell lung cancer (NSCLC). Developed in partnership with the EGFR Resisters patient advocacy community, the summit delivers immersive research and career development training through a rich variety of modalities, including direct interaction with a select group of esteemed faculty, peers, and public speaking coaches.
More than a traditional conference, EGFR-RRS is designed to accelerate careers and forge lasting connection. Finalists participate in oral presentations of their work, receive individualized mentorship and feedback, and engage in dynamic small-group discussions and networking opportunities that spark collaboration well beyond the summit itself. The result is a singular experience that empowers early-career investigators to grow as scientists, communicators, and future leaders in the field.
Target Audience
North American-based junior faculty and fellows (MDs, MD/PhDs) involved in research related to NSCLC (specifically EGFRm)
Learning Objectives
- Assess the impact of scholarly activity and clinical research on continuing professional development in medicine
- Evaluate strengths and weaknesses of lung cancer research presented by investigator peers
- Incorporate public speaking and presentation skills effectively for the presentation of research findings to the larger medical and scientific community
- Explore “what it takes” to become a lung cancer researcher by discussing career challenges such as grant writing, research funding, academic appointments, etc. with leading expert investigators
Call for Abstracts
Submission Deadline
Friday, August 28, 2026
“This meeting has helped me get a better sense of how to ground my research in what can be translated to positively impact patients.” —Prior EGFR Resisters Research Summit Participant
“[The most impactful things from the Summit were] learning how to partner with patient advocates and the power of these partnerships for enhancing research.” —Prior EGFR Resisters Research Summit Participant

. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Fee
There is no fee to attend this activity.

